Chemo-Immunotherapy Regimes for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis

• Asıl Yazarlar: Youwen Zhu (Yazar), Kun Liu (Yazar), Dong Ding (Yazar), Kailing Wang (Yazar), Xiaoting Liu (Yazar), Xiao Tan (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Introduction: In 2021, two phase III clinical trials confirmed that toripalimab or camrelizumab combined with gemcitabine and cisplatin (TGP or CGP) provide more benefits in the first-line treatment of R/M NPC than GP. Fortunately, TGP and CGP were recently approved as first-line treatments for case...